A change in FTC leadership would likely see a relaxation of antitrust enforcement and an increase in biopharma M&A activity.

"I am totally against the once great and powerful U.S. Steel being bought by a foreign company, in this case Nippon Steel of ...

Kalyanaraman has made a stunning return to the 2024 Forbes India Rich List, with a personal wealth of $5.38 billion that also ...